Updated Jul 16, 2026
Ellis Andrea has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $6.49M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-13 | BBIO | BridgeBio Pharma, Inc. | S — Open-market sale [10b5-1] | 17.2K | $84.00 | $1.44M |
| 2026-07-13 | BBIO | BridgeBio Pharma, Inc. | M — Option exercise [10b5-1] | 17.2K | $16.75 | $288K |
| 2026-06-24 | BBIO | BridgeBio Pharma, Inc. | A — Grant or award | 4.0K | $0.00 | |
| 2026-03-06 | BBIO | BridgeBio Pharma, Inc. | S — Open-market sale [10b5-1] | 64.9K | $64.87 | $4.21M |
| 2026-03-06 | BBIO | BridgeBio Pharma, Inc. | M — Option exercise [10b5-1] | 64.9K | $8.45 | $549K |
| 2025-08-05 | BBIO | BridgeBio Pharma, Inc. | S — Open-market sale | 17.2K | $49.00 | $841K |
| 2025-08-05 | BBIO | BridgeBio Pharma, Inc. | M — Option exercise | 17.2K | $16.75 | $288K |
Ellis Andrea is a corporate insider — currently tracked as Director of BridgeBio Pharma, Inc. (BBIO). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($6.49M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Ellis Andrea profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.